Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings Breadth of Scientific ...
Research posters should be more than academic advertisements—or, conversely, overwhelming data dumps that attempt to compress ...
Acquisition of Vectura strengthened inhalation capabilities, driving innovation and portfolio expansion in less than one ...
BriaCell presents positive clinical data in three posters at the San Antonio Breast Cancer Symposium (SABCS®) Phase 3 study ...
"Our significant showcase at ASH this year reflects Parexel’s specialized scientific and medical expertise in hematology and our commitment to partnering with leading biopharma sponsors to advance ...
Lee University natural science students, Alexa VanVeghten and Karina Dilse, presented research posters at the 2025 Tennessee ...
SFC/SFE Japan 2026—the 20th International Conference on Packed Column Supercritical Fluid Chromatography, Supercritical Fluid ...
InvestorsHub on MSN
Abivax shares gain after 22 scientific abstracts accepted for ECCO 2026
Abivax SA ADR (NASDAQ:ABVX) shares rose 2.6% in premarket trading on Thursday after the clinical-stage biotechnology company announced that 22 scientific abstracts have been accepted for presentation ...
LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting Eight scientific posters demonstrate significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback